Abstract
Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy followed by definitive local treatment should be the treatment of choice for otherwise healthy and robust patients with T2b–T4 invasive bladder cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have